Allworth Financial LP Bio Techne Corp Transaction History

Allworth Financial LP

$16.1 Billion
Q3 2024

A detailed history of Allworth Financial LP transactions in Bio Techne Corp stock. As of the latest transaction made, Allworth Financial LP holds 1,699 shares of TECH stock, worth $121,104. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,699

Previous 886 91.76%

Holding current value

$121,104

Previous $63,000 114.29%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$70.96 - $82.35 $57,690 - $66,950	813 Added 91.76%	1,699 $135,000
Q2 2024 Jul 23, 2024	BUY	$62.12 - $84.15 $33,420 - $45,272	538 Added 154.6%	886 $63,000
Q1 2024 Apr 25, 2024	BUY	$65.98 - $77.09 $3,167 - $3,700	48 Added 16.0%	348 $24,000
Q4 2023 Jan 24, 2024	BUY	$52.83 - $78.22 $10,196 - $15,096	193 Added 180.37%	300 $23,000
Q3 2023 Oct 31, 2023	SELL	$67.52 - $89.42 $13,774 - $18,241	-204 Reduced 65.59%	107 $7,000
Q2 2023 Jul 18, 2023	BUY	$73.76 - $85.98 $811 - $945	11 Added 3.67%	311 $25,000
Q1 2023 Apr 18, 2023	BUY	$71.62 - $86.62 $2,864 - $3,464	40 Added 15.38%	300 $22,000
Q4 2022 Jan 13, 2023	BUY	$80.67 - $352.29 $19,441 - $84,901	241 Added 1268.42%	260 $0
Q3 2022 Oct 18, 2022	SELL	$282.54 - $391.85 $6,780 - $9,404	-24 Reduced 55.81%	19 $5,000
Q2 2022 Jul 13, 2022	SELL	$322.67 - $449.65 $3,549 - $4,946	-11 Reduced 20.37%	43 $15,000
Q1 2022 Apr 22, 2022	BUY	$353.85 - $487.79 $17,692 - $24,389	50 Added 1250.0%	54 $23,000
Q4 2021 Jan 21, 2022	SELL	$456.15 - $525.06 $10,035 - $11,551	-22 Reduced 84.62%	4 $2,000
Q3 2021 Nov 02, 2021	BUY	$444.87 - $538.88 $11,566 - $14,010	26 New	26 $13,000

Others Institutions Holding TECH

# of Institutions

601

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.

Account

Allworth Financial LP Bio Techne Corp Transaction History